These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6368290)

  • 1. Culture and phenotype of activated T-cells from patients with type I diabetes mellitus.
    Hayward AR; Herberger M
    Diabetes; 1984 Apr; 33(4):319-23. PubMed ID: 6368290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subsets and activation in prediabetes.
    Hitchcock CL; Riley WJ; Alamo A; Pyka R; Maclaren NK
    Diabetes; 1986 Dec; 35(12):1416-22. PubMed ID: 3533686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method.
    Kobayashi T; Sugimoto T; Itoh T; Kosaka K; Tanaka T; Suwa S; Sato K; Tsuji K
    Diabetes; 1986 Mar; 35(3):335-40. PubMed ID: 3512344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus.
    Roep BO; Duinkerken G; Schreuder GM; Kolb H; de Vries RR; Martin S
    Eur J Immunol; 1996 Jun; 26(6):1285-9. PubMed ID: 8647206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.
    Harrison LC; Chu SX; DeAizpurua HJ; Graham M; Honeyman MC; Colman PG
    J Clin Invest; 1992 Apr; 89(4):1161-5. PubMed ID: 1556180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes.
    Harrison LC; De Aizpurua H; Loudovaris T; Campbell IL; Cebon JS; Tait BD; Colman PG
    Diabetes; 1991 Sep; 40(9):1128-33. PubMed ID: 1936620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant activation of CD8+ T-cell and CD8+ T-cell subsets in patients with newly diagnosed IDDM.
    Hehmke B; Michaelis D; Gens E; Laube F; Kohnert KD
    Diabetes; 1995 Dec; 44(12):1414-9. PubMed ID: 7589848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects.
    Schloot NC; Roep BO; Wegmann D; Yu L; Chase HP; Wang T; Eisenbarth GS
    Diabetologia; 1997 May; 40(5):564-72. PubMed ID: 9165225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1-like cytokine production profile and individual specific alterations in TCRBV-gene usage of T cells from newly diagnosed type 1 diabetes patients after stimulation with beta-cell antigens.
    Kallan AA; Duinkerken G; de Jong R; van den Elsen P; Hutton JC; Martin S; Roep BO; de Vries RR
    J Autoimmun; 1997 Dec; 10(6):589-98. PubMed ID: 9451599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell reactivity to beta-cell membrane antigens associated with beta-cell destruction in IDDM.
    Roep BO; Kallan AA; Duinkerken G; Arden SD; Hutton JC; Bruining GJ; de Vries RR
    Diabetes; 1995 Mar; 44(3):278-83. PubMed ID: 7883114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immune response to diverse islet cell antigens in IDDM.
    Durinovic-Bellò I; Hummel M; Ziegler AG
    Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
    Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
    Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated autoimmunity at the onset of insulin-dependent diabetes mellitus (IDDM).
    Ziegler AG; Standl E; Lander T; Nerl C; Rieber EP; Mehnert H
    Klin Wochenschr; 1987 Jul; 65(12):546-50. PubMed ID: 3306133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro secretion of interleukin 2 and expression of IL-2 receptor in peripheral blood lymphocytes in high risk of insulin-dependent diabetes mellitus subjects.
    Kretowski A; Myśliwiec J; Szelachowska M; Brzozowski C; Pietruczuk M; Kinalska I
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):45-9. PubMed ID: 11729828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to insulin and lymphocyte subclasses at diagnosis of insulin-dependent diabetes and one year later.
    Scheinin T; Mäenpää J; Kontiainen S
    Immunobiology; 1990 Jun; 180(4-5):431-40. PubMed ID: 2204602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of autologous mixed leukocyte reaction in type 1 diabetes mellitus by in vivo-activated T lymphocytes.
    Räsänen L; Hyöty H; Lehto M; Kallioniemi OP; Huupponen T; Tuomilehto-Wolf E; Kaprio E; Leinikki P
    Clin Immunol Immunopathol; 1989 Sep; 52(3):406-13. PubMed ID: 2527100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR binding analysis of peptides from islet antigens in IDDM.
    Geluk A; van Meijgaarden KE; Schloot NC; Drijfhout JW; Ottenhoff TH; Roep BO
    Diabetes; 1998 Oct; 47(10):1594-601. PubMed ID: 9753297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.